JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NTST
2301
NETSTREIT Corp
NTST
$1.77B
| $14.4M | ﹤0.01% |
818,224
+202,928
| +33% | +$3.69M |
2020 Q3
21 quarters
|
|
2302
CALL
Intercontinental Exchange
ICE
$85B
| $14.4M | ﹤0.01% |
89,100
| – | – |
2023 Q3
9 quarters
|
|
2303
PUT
MGM Resorts International
MGM
$7.67B
| $14.4M | ﹤0.01% |
395,000
| – | – |
2022 Q1
15 quarters
|
|
2304
Matsons
MATX
$6.74B
| $14.4M | ﹤0.01% |
116,531
-42,930
| -27% | -$4.61M |
2013 Q2
50 quarters
|
|
2305
CALL
State Street Technology Select Sector SPDR ETF
XLK
$129B
| $14.4M | ﹤0.01% |
100,000
| – | – |
2023 Q3
9 quarters
|
|
2306
First Trust Senior Loan Fund ETF
FTSL
$2.43B
| $14.4M | ﹤0.01% |
313,750
+154,662
| +97% | +$7.09M |
2021 Q1
19 quarters
|
|
2307
IBEX
IBEX
$588M
| $14.4M | ﹤0.01% |
376,941
+29,358
| +8% | +$1.09M |
2020 Q3
21 quarters
|
|
2308
iShares Global Equity Factor ETF
GLOF
$197M
| $14.3M | ﹤0.01% |
271,771
-51,640
| -16% | -$2.7M |
2025 Q1
3 quarters
|
|
2309
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.16B
| $14.3M | ﹤0.01% |
62,162
-4,480
| -7% | -$1.03M |
2015 Q4
40 quarters
|
|
2310
Dimensional US Marketwide Value ETF
DFUV
$15.2B
| $14.3M | ﹤0.01% |
307,572
-6,889
| -2% | -$312K |
2022 Q4
12 quarters
|
|
|
NVO
2311
CALL
Novo Nordisk
NVO
$165B
| $14.3M | ﹤0.01% |
281,500
-251,400
| -47% | -$12.9M |
2025 Q3
1 quarter
|
|
2312
Cavco Industries
CVCO
$4.44B
| $14.3M | ﹤0.01% |
24,237
-7,820
| -24% | -$4.43M |
2015 Q4
40 quarters
|
|
2313
Advanced Energy
AEIS
$11.8B
| $14.3M | ﹤0.01% |
68,193
-173,489
| -72% | -$35.3M |
2013 Q2
50 quarters
|
|
2314
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.62B
| $14.3M | ﹤0.01% |
332,936
+5,509
| +2% | +$236K |
2018 Q2
30 quarters
|
|
2315
PUT
VanEck Durable High Dividend ETF
DURA
$36.8M
| $14.3M | ﹤0.01% |
50,100
+100
| +0.2% | +$3.37K |
2023 Q3
9 quarters
|
|
2316
Cogent Biosciences
COGT
$5.48B
| $14.2M | ﹤0.01% |
400,931
+326,119
| +436% | +$9.17M |
2020 Q4
20 quarters
|
|
2317
PUT
Texas Instruments
TXN
$257B
| $14.2M | ﹤0.01% |
82,000
-84,000
| -51% | -$14.4M |
2016 Q4
36 quarters
|
|
2318
CALL
Elevance Health
ELV
$82.8B
| $14.2M | ﹤0.01% |
40,500
-12,500
| -24% | -$4.22M |
2021 Q3
17 quarters
|
|
2319
Equity Bancshares
EQBK
$978M
| $14.2M | ﹤0.01% |
317,786
-32,761
| -9% | -$1.4M |
2017 Q3
33 quarters
|
|
2320
Prestige Consumer Healthcare
PBH
$2.12B
| $14.2M | ﹤0.01% |
229,506
-229,722
| -50% | -$14.1M |
2013 Q2
50 quarters
|
|
|
FOPC
2321
Frontier Asset Opportunistic Credit ETF
FOPC
$31.9M
| $14.2M | ﹤0.01% |
553,813
+19,343
| +4% | +$500K |
2024 Q4
4 quarters
|
|
2322
First American
FAF
$6.28B
| $14.1M | ﹤0.01% |
230,185
+64,387
| +39% | +$4.04M |
2013 Q2
50 quarters
|
|
2323
Vontier
VNT
$4.25B
| $14.1M | ﹤0.01% |
380,052
-47,395
| -11% | -$1.81M |
2020 Q4
20 quarters
|
|
2324
Silicon Laboratories
SLAB
$7.42B
| $14.1M | ﹤0.01% |
108,059
-26,501
| -20% | -$3.48M |
2015 Q4
40 quarters
|
|
2325
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
| $14.1M | ﹤0.01% |
294,264
-32,323
| -10% | -$1.55M |
2013 Q2
50 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.